Bio-Rad Laboratories, Inc. announced that Roop K. Lakkaraju will be joining the company as its new Executive Vice President and Chief Financial Officer starting April 15, 2024. Mr. Lakkaraju brings with him extensive experience in financial management, operations, and mergers and acquisitions from his previous roles at Benchmark Electronics and other multinational companies. His background in audit and finance, along with his track record in capital markets transactions, make him a valuable addition to Bio-Rad’s leadership team.
Norman Schwartz, Bio-Rad’s President and CEO, expressed his excitement about welcoming Roop Lakkaraju as the new CFO, citing his expertise in shaping and executing financial strategies. Mr. Lakkaraju, in turn, expressed his enthusiasm for the role, stating his commitment to driving financial and strategic initiatives that will create long-term value for all stakeholders. With Bio-Rad’s focus on developing innovative products for life science research and clinical diagnostics markets, Mr. Lakkaraju’s leadership is expected to play a key role in advancing the company’s mission to save lives through scientific advancements and high-quality products.
Bio-Rad Laboratories, Inc. is a global leader in the development, manufacturing, and marketing of products for various scientific and medical markets. With over 8,000 employees worldwide and revenues of $2.7 billion in 2023, Bio-Rad operates with a commitment to advancing science and improving healthcare outcomes. Mr. Lakkaraju’s appointment as the new CFO signals a new chapter in Bio-Rad’s financial strategy, aimed at furthering the company’s mission of innovation and excellence in life sciences.